Cannabinoids and the Coronavirus
Kevin P. Hill
Abstract
Cannabis and Cannabinoid ResearchVol. 5, No. 2 PerspectiveCannabinoids and the CoronavirusKevin P. HillKevin P. Hill*Address correspondence to: Kevin P. Hill, MD, MHS, Division of Addiction Psychiatry, Beth Israel Deaconess Medical Center, Gryzmish 133, 330 Brookline Avenue, Boston, MA 02215, USA, E-mail Address: [email protected]Division of Addiction Psychiatry, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.Search for more papers by this authorPublished Online:5 Jun 2020https://doi.org/10.1089/can.2020.0035AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookXLinked InRedditEmail View articleFiguresReferencesRelatedDetailsCited byAn overview of phytochemical constituents and pharmacological implications of Cannabis sativa L.Journal of Herbal Medicine, Vol. 42Antiviral Activity of Cannabidiolic Acid and Its Methyl Ester against SARS-CoV-24 July 2023 | Journal of Natural Products, Vol. 86, No. 7Impact of nutraceuticals on immunomodulation against viral infections—A review during COVID‐19 pandemic in Indian scenario17 February 2023 | Journal of Biochemical and Molecular Toxicology, Vol. 37, No. 5Endocannabinoid System: Chemical Characteristics and Biological Activity19 January 2023 | Pharmaceuticals, Vol. 16, No. 2Analyzing sentiments and themes on cannabis in Canada using 2018 to 2020 Twitter data13 April 2022 | Journal of Cannabis Research, Vol. 4, No. 1Activity of THC, CBD, and CBN on Human ACE2 and SARS-CoV1/2 Main Protease to Understand Antiviral Defense Mechanism12 October 2021 | Planta Medica, Vol. 88, No. 12Identification of SARS-CoV-2 Main Protease Inhibitors from a Library of Minor Cannabinoids by Biochemical Inhibition Assay and Surface Plasmon Resonance Characterized Binding Affinity19 September 2022 | Molecules, Vol. 27, No. 18The Medicinal Natural Products of Cannabis sativa Linn.: A Review4 March 2022 | Molecules, Vol. 27, No. 5A review of natural products, their effects on SARS-CoV-2 and their utility as lead compounds in the discovery of drugs for the treatment of COVID-192 December 2021 | Medicinal Chemistry Research, Vol. 31, No. 1Implications of Cannabis and Cannabinoid Use in COVID-19: Scoping Review1 January 2022 | Revista Brasileira de Enfermagem, Vol. 75, No. suppl 1Antimicrobial and Antiviral (SARS-CoV-2) Potential of Cannabinoids and Cannabis sativa: A Comprehensive Review28 November 2021 | Molecules, Vol. 26, No. 23"Natural medicinal plant products as an immune-boosters: A possible role to lessen the impact of Covid-19"Case Studies in Chemical and Environmental Engineering, Vol. 2020Medical cannabis education among healthcare trainees: A scoping reviewComplementary Therapies in Medicine, Vol. 58Electrochemical sensing: A prognostic tool in the fight against COVID-19TrAC Trends in Analytical Chemistry, Vol. 136Could Cannabidiol Be a Treatment for Coronavirus Disease-19-Related Anxiety Disorders? Saoirse E. O'Sullivan, Carl W. Stevenson, and Steven R. Laviolette12 February 2021 | Cannabis and Cannabinoid Research, Vol. 6, No. 1Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-1917 February 2021 | International Journal of Molecular Sciences, Vol. 22, No. 4Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approachesInternational Journal of Biological Macromolecules, Vol. 168Supporting Persons Who Use Drugs During the COVID-19 Pandemic: A Rapid Review of International Guidelines1 June 2021 | Canadian Journal of Addiction, Vol. 12, No. 2Cannabis and COVID-19: Reasons for Concern21 December 2020 | Frontiers in Psychiatry, Vol. 11SARS-CoV-2 and mitochondrial health: implications of lifestyle and ageing9 November 2020 | Immunity & Ageing, Vol. 17, No. 1Potentials of plant-based substance to inhabit and probable cure for the COVID-1921 June 2020 | TURKISH JOURNAL OF BIOLOGY, Vol. 44, No. 3 Volume 5Issue 2Jun 2020 InformationCopyright 2020, Mary Ann Liebert, Inc., publishersTo cite this article:Kevin P. Hill.Cannabinoids and the Coronavirus.Cannabis and Cannabinoid Research.Jun 2020.118-120.http://doi.org/10.1089/can.2020.0035Published in Volume: 5 Issue 2: June 5, 2020Online Ahead of Print:April 28, 2020 TopicsCannabinoidsCannabisCoronary artery diseaseCoronaviruses PDF download